Loading insider details...
Latest Form 4 (Sep 1, 2026): Sale of 6,368 XENE shares, $383.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 6,368 | $383.1K |
| Mar 14, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 3,750 | n/a |
| Mar 11, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 7,500 | n/a |
| Jan 9, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 100,000 | n/a |
| Mar 13, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 80,000 | n/a |
| Mar 12, 2024 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 100,000 | n/a |
| Mar 24, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Sale | 700 | $24.5K |
| Mar 14, 2023 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 120,000 | n/a |
| Mar 14, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 125,000 | n/a |
| Jan 21, 2022 | Xenon Pharmaceuticals Inc. (XENE) | Purchase | 700 | $20.2K |